Background: Venous thromboembolism (VTE) is a major cause of mortality. Factor V Leiden (FVL), methylenetetrahydrofolate reductase (MTHFR) C677T, and prothrombin (FII) G20210A polymorphisms are the main inherited risk factors for VTE. Since evidence is limited on homozygotes, the aim of this study was to investigate the association between homozygous variants of these polymorphisms and VTE in Shahrekord, southwest Iran.
INTRODUCTION
Venous thromboembolism is a disease in which both inherited and acquired factors may be involved. Although the real prevalence of VTE, consisting of deep venous thrombosis (DVT) and pulmonary embolism (PE), remains to be determined in many communities, it is known to be one of the main causes of mortality. In the United States, VTE is considered as the third leading cause of mortality and a leading cause of unpredictable deaths (1) . Even the people who survive PE have a lower quality of life than healthy people (2) .
Coagulation factor deficiencies, platelets abnormalities, impaired vessel wall, and coagulation inhibitors can contribute to developing thrombosis. Thrombophilia is a
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Factor V Leiden (FVL), prothrombin (FII) G20210A, and methyltetrahydrofolate reductase (MTHFR) C677T
polymorphisms are the main risk factors for VTE.
Moreover, the role of factor XIII and platelet glycoprotein IIb/IIIa has been recently considered in VTE (3, 4) . FVL is a mutation of coagulation factor V that makes FVL resistant to protein C, its inhibitor (5) . MTHFR plays an important role in maintaining homocysteine level. The C677T polymorphism of MTHFR molecule makes the enzyme heat resistant and may increase serum homocysteine which is a predisposing factor for thrombosis (6) . The MTHFR C677T has been reported to be associated with increased VTE in a Chinese population but some conflicting data have been reported in other ethnicities (7) . The FIIG20210A polymorphism is associated with increased plasma prothrombin level and increased risk of venous thrombosis (8) , and the FIIG20210A carriers are at 2-3 times higher risk for developing VTE (9, 10) . The frequencies of these polymorphisms vary depending on the racial origins in both normal and VTE patient populations (9) (10) (11) , and the available data confirm widely variable distribution of different polymorphisms.
We have already found that PLA2 polymorphism of platelet glycoprotein IIb-IIIa is associated with increased risk of developing VTE and severity of PE (3, 12) . Because homozygosity in any of the polymorphisms can increase the gene products and relevant data are limited, the aim of this study was to investigate the association between homozygous variants of these mutations and VTE.
MATERIALS AND METHODS
Patients
In this study, 72 patients with VTE who were admitted The genes of interest were amplified by a thermocycler (ASTEC, PC818, Japan). The primers which were used to investigate each mutation were designed according to Ivanov et al. study (13) , and are listed in Table 1 and the primers were purchased from Fermentase (Russia).
An 8% polyacrylamide gel was used to investigate the final products and the bands were observed by Coomassie Brilliant Blue staining. The thermal cycling programs of the studied polymorphisms were as follows:
FVL mutation: Four minutes at 96°C, six cycles of 60 seconds at 96°C, 60 seconds at 58°C, and 60 seconds at 72°C, followed by 28 cycles of 30 seconds at 96°C, 30 seconds at 56°C, and 30 seconds at 72°C, and a final extension of 5 minutes at 72°C. 
Statistical analysis
The data were analyzed by SPSS 18. Descriptive statistics were used for the demographic characteristics.
The significance of the differences in the distribution of homozygous polymorphisms between the patients and the controls was investigated by chi-square test, and P<0.05
was considered significant. Moreover, the odds ratio (OR) was used to represent the association of the polymorphisms with VTE.
RESULTS
Demographic characteristics of patients
Thirty-seven patients had PE and the remaining had DVT. The mean age of the patients was 42.12±18.59 years; 40.27% of the patients were males. The mean age of male patients was lower than that of female patients with no significant difference (P>0.05). There was no significant difference in the age of patients with homozygous and heterozygous mutations.
Homozygous and heterozygous polymorphisms in patients
Out of 72 studied patients, 16.66% and out of controls, 4.90% had homozygous mutations of the studied polymorphisms (P=0.004, Table 2 ). FVL was seen in four (5.55%) patients, MTHFR C677T in 32 (44.14%), and FIIG20210A in one (1.4%) patient. Table 3 compares the   frequency  of  heterozygous  and  homozygous polymorphisms between the patients and controls. Figure   1 illustrates the PCR-RFLP products of FVL, MTHFR C677T, and FIIG20210A on polyacrylamide gel. 
DISCUSSION
This study demonstrated that VTE was associated with a number of homozygous thrombophilic polymorphisms, and some of the known thrombophilic homozygous polymorphisms increased the risk of developing VTE, while others had no effect. In a study on factor XIII polymorphisms, homozygous FXIIIA-V34L was found to protect against VTE, while heterozygous FXIIIA-V34L and XIIIB-H95R had no effect (4). Besides, the frequency of coincidence of thrombophilic mutations was found to be higher in DVT patients than in PE patients and controls (14) . In a study conducted in an Australian Caucasian population, 64.2% and 24.5% of studied group were homozygous and heterozygous, respectively at least for one of the inherited thrombophilia; these values are higher than our findings (15) . Among the patients in our study, the most frequent homozygous polymorphism was found to be MTHFR C677T (11.11%). This polymorphism is distributed among all populations and is more frequent in some racial populations (9, 10) . It has been found more The frequency of homozygous MTHFR C677T was 3.9% in the controls in our study, which was relatively lower than the values reported from Europe and Australia (15, 18) . The significantly higher frequency of homozygous MTHFR C677T in patients than controls in our study is inconsistent with the results of Ivanov et al, reporting a higher frequency in the control group (13) . In carriers of heterozygous mutation, enzyme function is about 65% of its normal level, whereas, this rate is only 30% in homozygous mutation (6) . The presence of this polymorphism causes an increase in plasma homocysteine level that can contribute to the pathogenesis of arterial and venous thrombosis (19, 20) . Kokturk et al. reported increased plasma homocysteine levels in patients, such that the risk of developing VTE increased by 4.8 times (20) . In their study, the prevalence of homocysteinemia in VTE was 63% and higher in PE patients compared to DVT.
Moreover, increased homocysteine can be due to systemic or endothelial oxidative stress which leads to platelet activation (21).
Homozygous FVL was more frequent in patients than in controls (2.77% vs. 0.32%) in our study, yet with no significant difference. Different studies have investigated the contribution of FVL mutation to VTE and reported various frequencies of this mutation in different populations (9, 22, 23 (24) . In a study in Turkey, homozygous FVL was significantly associated with thrombosis; whereas, MTHFR C677T was equally distributed in patients and controls (25) , but in a Chinese population, FVL mutation was not associated with VTE, which is in agreement with our findings (9). The inconsistent findings of different studies can be explained by the racial origins and also the environmental risk factors influencing the whole population of a community, including people without these polymorphisms, and making them predisposed to thrombosis.
FIIG20210A mutation was not associated with VTE in our study which is consistent with the results of Bezgin et al, who found similar frequencies of this mutation in patients with different manifestations of VTE and controls (26) . Some studies have reported the association of FIIG20210A mutation with VTE pathogenesis (8), while some others have found such associations in Caucasians but not in Chinese/Thai or African American populations (9) . The latter is in agreement with our study.
Coinheritance of thrombophilic factors can reduce the predisposition to bleeding in hemophilia patients (27) but increase the risk of thrombosis in VTE patients (3). We had two patients but no controls with coinheritance of homozygous FVL and MTHFR C677T in this study.
Because of the limited number of patients in our study, we could not investigate the significance of such coinheritance.
We studied a limited number of homozygous 
